Cargando…
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
BACKGROUND: Neoadjuvant chemotherapy for breast cancer leads to considerable variability in clinical responses, with only 10 to 20% of cases achieving complete pathologic responses (pCR). Biological and clinical factors that determine the extent of pCR are incompletely understood. Mounting evidence...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240891/ https://www.ncbi.nlm.nih.gov/pubmed/25419236 http://dx.doi.org/10.1186/s13073-014-0080-8 |